VICP Registry Case Source Bundle
Canonical URL: https://vicp-registry.org/case/USCOURTS-cofc-1_14-vv-01156
Package ID: USCOURTS-cofc-1_14-vv-01156
Petitioner: Paula Pasquinelli
Filed: 2014-11-26
Decided: 2017-05-30
Vaccine: influenza
Vaccination date: 2012-01-12
Condition: anaphylactic reaction, weakness, Parsonage Turner Syndrome, peripheral neuropathy, and transverse myelitis
Outcome: compensated
Award amount USD: 35000

AI-assisted case summary:
Paula Pasquinelli filed a petition for compensation on November 26, 2014, alleging that she suffered from vaccine-induced anaphylactic reaction, weakness, Parsonage Turner Syndrome, peripheral neuropathy, and transverse myelitis as a result of receiving influenza, hepatitis A, hepatitis B, polio, and Diphtheria-Tetanus-acellular Pertussis ("DTaP") vaccinations on January 12, 2012. The respondent denied that the vaccines caused the petitioner's alleged injuries or her current condition. The parties reached a settlement, and on May 3, 2017, they filed a joint stipulation agreeing to settle the case. The respondent agreed to issue a payment of $35,000.00 to Paula Pasquinelli as compensation for all damages. Special Master Mindy Michaels Roth adopted the stipulation and awarded compensation in the agreed-upon amount on May 30, 2017. The public decision does not describe the petitioner's counsel, respondent's counsel, the specific onset of symptoms, clinical details, medical tests, treatments, or expert witnesses. The public decision does not describe the specific mechanism of causation.

Theory of causation field:
Petitioner Paula Pasquinelli alleged that influenza, hepatitis A, hepatitis B, polio, and DTaP vaccinations administered on January 12, 2012, caused anaphylactic reaction, weakness, Parsonage Turner Syndrome, peripheral neuropathy, and transverse myelitis. Respondent denied causation. The parties reached a settlement, and Special Master Mindy Michaels Roth adopted the stipulation on May 30, 2017. The settlement awarded a lump sum of $35,000.00 to Paula Pasquinelli. The public text does not specify the theory of causation, the mechanism, or any expert testimony.

Public staged source text:

================================================================================
DOCUMENT 1: USCOURTS-cofc-1_14-vv-01156-0
Date issued/filed: 2017-05-30
Pages: 7
Docket text: PUBLIC DECISION (Originally filed: 5/04/2017) Regarding 56 DECISION Stipulation/Proffer. Signed by Special Master Mindy Michaels Roth. (jo) Copy to parties.
--------------------------------------------------------------------------------
Case 1:14-vv-01156-UNJ Document 58 Filed 05/30/17 Page 1 of 7
In the United States Court of Federal Claims
OFFICE OF SPECIAL MASTERS
No. 14-1156V
Filed: May 4, 2017
* * * * * * * * * * * * * * *
PAULA PASQUINELLI, * UNPUBLISHED
*
Petitioner, * Decision on Joint Stipulation;
v. * Anaphylactic Reaction, Weakness,
* Parsonage Turner Syndrome, Peripheral
SECRETARY OF HEALTH * Neuropathy, and Transverse Myelitis
AND HUMAN SERVICES, * (“TM”); Influenza (“Flu”), Hepatitis A
* (“Hep A”), Hepatitis B (“Hep B”), Polio,
Respondent. * and Diphtheria-Tetanus-acellular Pertussis
* (“DTaP”) Vaccines.
* * * * * * * * * * * * * * *
Mark T. Sadaka, Esq., Mark T. Sadaka, LLC, Englewood, NJ, for petitioner.
Adriana R. Teitel, Esq., U.S. Department of Justice, Washington, DC, for respondent.
DECISION ON JOINT STIPULATION1
Roth, Special Master:
On November 26, 2014, Petitioner (“Mr. Pasquinelli,” or “petitioner”) filed a petition for
compensation under the National Vaccine Injury Compensation Program.2 Petitioner alleged
that she suffered from vaccine-induced anaphylactic reaction, weakness, Parsonage Turner
Syndrome, peripheral neuropathy, and transverse myelitis as a result of receiving an influenza,
hepatitis A, hepatitis B, polio, and Diphtheria-Tetanus-acellular Pertussis (“DTaP”) vaccinations
on January 12, 2012. See Stipulation, filed May 4, 2017, at ¶¶ 1-4. Respondent denies that
petitioner’s alleged injuries and their residual effects were caused-in-fact or significantly
1 Because this unpublished decision contains a reasoned explanation for the action in this case, I
intend to post this decision on the United States Court of Federal Claims’ website, in accordance with the
E-Government Act of 2002, Pub. L. No. 107-347, § 205, 116 Stat. 2899, 2913 (codified as amended at 44
U.S.C. § 3501 note (2012)). In accordance with Vaccine Rule 18(b), a party has 14 days to identify and
move to delete medical or other information, that satisfies the criteria in 42 U.S.C. § 300aa-12(d)(4)(B).
Further, consistent with the rule requirement, a motion for redaction must include a proposed redacted
decision. If, upon review, I agree that the identified material fits within the requirements of that
provision, I will delete such material from public access.
2 National Childhood Vaccine Injury Act of 1986, Pub. L. No. 99-660, 100 Stat. 3755.
Hereinafter, for ease of citation, all “§” references to the Vaccine Act will be to the pertinent
subparagraph of 42 U.S.C. § 300aa (2012).
1

Case 1:14-vv-01156-UNJ Document 58 Filed 05/30/17 Page 2 of 7
aggravated by her vaccine. Respondent further denies that the vaccines caused petitioner any
other injury or her current condition. Id. at ¶ 6.
Nevertheless, the parties have agreed to settle the case. On May 3, 3017, the parties filed
a joint stipulation agreeing to settle this case and describing the settlement terms. Respondent
agrees to issue the following payment:
A lump sum of $35,000.00 in the form of a check payable to petitioner, Paula
Pasquinelli. This amount represents compensation for all damages that would be
available under § 300aa-15(a).
I adopt the parties’ stipulation attached hereto, and award compensation in the amount
and on the terms set forth therein. The clerk of the court is directed to enter judgment in
accordance with this decision.3
IT IS SO ORDERED.
s/ Mindy Michaels Roth
Mindy Michaels Roth
Special Master
3 Pursuant to Vaccine Rule 11(a), entry of judgment can be expedited by each party filing a notice
renouncing the right to seek review.
2

Case 1:14-vv-01156-UNJ Document 58 Filed 05/30/17 Page 3 of 7

Case 1:14-vv-01156-UNJ Document 58 Filed 05/30/17 Page 4 of 7

Case 1:14-vv-01156-UNJ Document 58 Filed 05/30/17 Page 5 of 7

Case 1:14-vv-01156-UNJ Document 58 Filed 05/30/17 Page 6 of 7

Case 1:14-vv-01156-UNJ Document 58 Filed 05/30/17 Page 7 of 7